276 related articles for article (PubMed ID: 12937161)
1. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
[TBL] [Abstract][Full Text] [Related]
2. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
[TBL] [Abstract][Full Text] [Related]
3. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
[TBL] [Abstract][Full Text] [Related]
4. In vitro model of annexin A5 crystallization on natural phospholipid bilayers observed by atomic force microscopy.
Irman S; Miha S; Igor M; Rozman B; Bozic B
Autoimmunity; 2009 Aug; 42(5):414-23. PubMed ID: 19811258
[TBL] [Abstract][Full Text] [Related]
5. The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies.
Irman S; Skarabot M; Muševič I; Rozman B; Božič B
J Autoimmun; 2011 Mar; 36(2):98-105. PubMed ID: 21185149
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.
Rand JH; Wu XX; Lapinski R; van Heerde WL; Reutelingsperger CP; Chen PP; Ortel TL
Blood; 2004 Nov; 104(9):2783-90. PubMed ID: 15242878
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Rand JH; Wu XX; Quinn AS; Ashton AW; Chen PP; Hathcock JJ; Andree HA; Taatjes DJ
Blood; 2010 Mar; 115(11):2292-9. PubMed ID: 19965621
[TBL] [Abstract][Full Text] [Related]
8. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2008 Oct; 17(10):922-30. PubMed ID: 18827057
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
Rand JH; Wu XX
Thromb Res; 2004; 114(5-6):383-9. PubMed ID: 15507268
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH
J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
[TBL] [Abstract][Full Text] [Related]
12. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy].
Peluso G; Morrone G
Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.
Rand JH
Am J Med Sci; 1998 Aug; 316(2):142-51. PubMed ID: 9704667
[TBL] [Abstract][Full Text] [Related]
14. The pathogenic role of annexin-V in the antiphospholipid syndrome.
Rand JH
Curr Rheumatol Rep; 2000 Jun; 2(3):246-51. PubMed ID: 11123066
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
Wu XX; Guller S; Rand JH
Am J Obstet Gynecol; 2011 Dec; 205(6):576.e7-14. PubMed ID: 21871597
[TBL] [Abstract][Full Text] [Related]
16. Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome.
Rand J; Eerden PV; Wu XX; Chazotte C
Thromb Res; 2005 Feb; 115 Suppl 1():77-81. PubMed ID: 15790162
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.
Wahezi DM; Ilowite NT; Rajpathak S; Rand JH
J Rheumatol; 2012 Feb; 39(2):382-8. PubMed ID: 22174207
[TBL] [Abstract][Full Text] [Related]
18. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
19. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
[TBL] [Abstract][Full Text] [Related]
20. Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.
Irman Š; Škarabot M; Muševič I; Rozman B; Božič B
EJIFCC; 2011 Jan; 21(4):81-93. PubMed ID: 27683378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
